SUPREX
Replacing China as API supplier for pharma will be a medium to long term story: Lupin‘In the case of Lupin, the actual API import from China is on the lower side.’
Next 2-3 years to be good for the company: Ramesh Swaminathan, LupinIn an interaction with ET Now, Ramesh Swaminathan, CFO, Lupin, talks about company's prospectus and expansion plans.
- Load More